Effects of intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF): a comprehensive multicenter phase 2 randomized clinical trial
Withdrawal of neurohumoral blockade in patients with normalized ejection fractions after cardiac resynchronization therapy: long-term follow-up of the STOP-CRT trial